Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter and supplier of Insulin Aspart 100 IU/ml Injection, delivering high-quality pharmaceutical formulations from India to international markets including the United States, United Kingdom, France, Germany, Switzerland, Belgium, Singapore, UAE, Saudi Arabia, Nigeria, Kenya, South Africa, Vietnam, Philippines, Indonesia, Brazil, and Mexico.
About Insulin Aspart 100 IU/ml Injection
Insulin Aspart is a rapid-acting insulin analog used to control high blood sugar levels in patients with diabetes mellitus. It helps in improving post-meal glucose control and is widely prescribed as part of insulin therapy.
Uses of Insulin Aspart
Management of Type 1 Diabetes Mellitus
Management of Type 2 Diabetes Mellitus when insulin is required
Control of postprandial (after meal) blood glucose levels
Used in combination with long-acting insulin formulations
Dosage Information
Dosage is strictly individualized based on patient condition, diet, and blood glucose levels
Administered subcutaneously (under the skin) before meals
Should be used only under supervision of a qualified healthcare professional
Do not self-adjust dose without medical guidance
Possible Side Effects
Hypoglycemia (low blood sugar)
Injection site reactions (redness, swelling, itching)
Weight gain
Lipodystrophy (fat tissue changes at injection site)
Allergic reactions (rare but possible)
Patients must consult a healthcare provider immediately in case of severe side effects.
Global Export & Supply by Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals ensures:
WHO-GMP compliant manufacturing standards
Reliable global pharmaceutical export network
Secure packaging and quality assurance
Fast and efficient international delivery solutions
We are committed to supplying high-quality insulin formulations to hospitals, distributors, wholesalers, and pharmaceutical importers worldwide.
Contact for Business Inquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Connect with us for bulk export inquiries, distributor partnerships, and global pharmaceutical supply requirements.
